EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Full-Length Immune Repertoire Reconstruction and Profiling at the Transcriptome Level Using Long-Read Sequencing

Xuanmei Luo, Lili Zhang, Yifei Li, Chang Li iD, Gaoyuan Sun, Chunli Zhang, Yu Fu, Haozhen Lv, Ming Liu, Hongyuan Cui, Dali Cai, Lihui Zou und 2 weitere

Clinical Chemistry · 2025

DOI: 10.1093/clinchem/hvae138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2025. Verfasst von Xuanmei Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of M…. Hauptthemen laut MEDLINE: Transcriptome, Gene Expression Profiling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High-Level Hospital Clinical Research Fund, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to the diversity of the immune repertoire (IR), reconstructing full-length IR using traditional short-read sequencing has proven challenging.

Methods

A full-length IR sequencing (FLIRseq) work flow was developed with linear rolling circle amplification and nanopore sequencing. Its accuracy and quantification ability were verified by plasmid mixtures and commercial B-cell receptor/T-cell receptor sequencing (BCR/TCR-seq) based on short reads. IRs in tissues and the peripheral blood from 8 patients with acute lymphoblastic leukemia, 3 patients with allergic diseases, 4 patients with psoriasis, and 5 patients with prostate cancer were analyzed using FLIRseq.

Results

FLIRseq reads had lower mismatch rates and gap rates, and higher identify rates than nanopore reads (all P < 2.2 × −16). The relative quantification of components by FLIRseq was consistent with the actual quantification (P > 0.05). FLIRseq had superiority over BCR/TCR-seq, providing the long complementarity-determining region 3, B-cell isotype, and the rarely used V gene sequence. FLIRseq observed an increase in clonotype diversity (P < 0.05) and a decrease in the percentage of abnormal BCRs/TCRs in patients with leukemia in remission. For patients with allergic diseases or psoriasis, FLIRseq provided direct insights into V(D)J recombination and specific immunoglobulin classes. Compared with that in prostate cancer tissues, the full-length V segment of the biased T-cell receptor β chain from lymphocytes in psoriatic tissues showed a more consistent AlphaFold2-predicted protein structure (P < 0.05).

Conclusions

FLIRseq enables unbiased and comprehensive analyses of direct V(D)J recombination and immunoglobulin classes, thereby contributing to characterizing pathogenic mechanisms, monitoring minimal residual disease, and customizing adoptive cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeGene Expression ProfilingHumansMaleProstatic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Antigen, B-CellReceptors, Antigen, T-CellPsoriasisHigh-Throughput Nucleotide SequencingHypersensitivity

Substanzen

Receptors, Antigen, B-CellReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Bei…
  • Department of Hematology, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Dermatology, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Urology, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Chang Li, Fei Xiao

Förderung

  • National High-Level Hospital Clinical Research Fund
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Luo, X., Zhang, L., Li, Y., Li, C., Sun, G., Zhang, C., Fu, Y., Lv, H., Liu, M., Cui, H., Cai, D., Zou, L., Ma, J., & Xiao, F. (2025). Full-Length Immune Repertoire Reconstruction and Profiling at the Transcriptome Level Using Long-Read Sequencing. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae138

Vancouver

Luo X, Zhang L, Li Y, Li C, Sun G, Zhang C, et al. Full-Length Immune Repertoire Reconstruction and Profiling at the Transcriptome Level Using Long-Read Sequencing. Clinical Chemistry. 2025. doi:10.1093/clinchem/hvae138

BibTeX
@article{Luo2025,
  author = {Luo, Xuanmei and Zhang, Lili and Li, Yifei and Li, Chang and Sun, Gaoyuan and Zhang, Chunli and Fu, Yu and Lv, Haozhen and Liu, Ming and Cui, Hongyuan and Cai, Dali and Zou, Lihui and Ma, Jie and Xiao, Fei},
  title = {Full-Length Immune Repertoire Reconstruction and Profiling at the Transcriptome Level Using Long-Read Sequencing},
  journal = {Clinical Chemistry},
  year = {2025},
  doi = {10.1093/clinchem/hvae138}
}
Kostenlos starten →